Literature DB >> 2539223

Residual tumour after biopsy for non-palpable ductal carcinoma in situ of the breast.

T Wobbes1, J G Tinnemans, R F van der Sluis.   

Abstract

In a group of 40 patients with non-palpable ductal carcinoma in situ (DCIS) of the breast, 41 breast specimens were available for studying residual tumour after biopsy. In one group of ten patients seen before 1977, simple histological examination revealed a 9 per cent incidence of residual tumour. However, after thorough examination residual foci of DCIS were found in 77 per cent of a subsequent group of 30 patients. This means that the majority of patients would have had to undergo reoperation if a breast-saving procedure had been performed. This fact must be taken into account when planning treatment of patients with non-palpable DCIS.

Entities:  

Mesh:

Year:  1989        PMID: 2539223     DOI: 10.1002/bjs.1800760226

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  4 in total

Review 1.  General surgery.

Authors:  I Taylor
Journal:  Postgrad Med J       Date:  1990-05       Impact factor: 2.401

Review 2.  Management of in situ and minimally invasive breast carcinoma.

Authors:  E R Frykberg; K I Bland
Journal:  World J Surg       Date:  1994 Jan-Feb       Impact factor: 3.352

Review 3.  Clinical decision-making in early breast cancer.

Authors:  C M Balch; S E Singletary; K I Bland
Journal:  Ann Surg       Date:  1993-03       Impact factor: 12.969

4.  Impact of an extensive in situ component on the presence of residual disease in screen detected breast cancer.

Authors:  I D Campbell; J M Theaker; G T Royle; R Coddington; R Carpenter; A Herbert; I Moore; C Rubin; I Taylor; P B Guyer
Journal:  J R Soc Med       Date:  1991-11       Impact factor: 18.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.